Related references
Note: Only part of the references are listed.Subsequent Type 2 Diabetes in Patients with Autoimmune Disease
Kari Hemminki et al.
SCIENTIFIC REPORTS (2015)
Association between diabetes mellitus and osteoarthritis: systematic literature review and meta-analysis
Karine Louati et al.
RMD OPEN (2015)
Risk of Rheumatoid Arthritis in Patients with Type 2 Diabetes: A Nationwide Population-Based Case-Control Study
Ming-Chi Lu et al.
PLOS ONE (2014)
Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study
Maureen Dubreuil et al.
RHEUMATOLOGY (2014)
DPP4 inhibitor-induced polyarthritis: a report of three cases
Etienne Crickx et al.
RHEUMATOLOGY INTERNATIONAL (2014)
Polyarthropathy in type 2 diabetes patients treated with DPP4 inhibitors
Tatsuhiko Saito et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2013)
Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance
Annayya R. Aroor et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
RS3PE in Association With Dipeptidyl Peptidase-4 Inhibitor: Report of Two Cases
K. Yamauchi et al.
DIABETES CARE (2012)
Sitagliptin (DPP-4 Inhibitor)-induced Rheumatoid Arthritis in Type 2 Diabetes Mellitus: A Case Report
Kazuki Yokota et al.
INTERNAL MEDICINE (2012)
Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis
Daniel H. Solomon et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Inhibition of Fibroblast Activation Protein and Dipeptidylpeptidase 4 Increases Cartilage Invasion by Rheumatoid Arthritis Synovial Fibroblasts
Caroline Ospelt et al.
ARTHRITIS AND RHEUMATISM (2010)
Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients
C. MUSCAT et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Approach to the Patient with Drug Allergy
Benno Schnyder
MEDICAL CLINICS OF NORTH AMERICA (2010)
Influence of HLA DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factor
Alejandro Balsa et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes
Debora Williams-Herman et al.
BMC ENDOCRINE DISORDERS (2010)
Acute onset of rheumatoid arthritis associated with administration of a dipeptidyl peptidase-4 (DPP-4) inhibitor to patients with diabetes mellitus
Takashi Sasaki et al.
DIABETOLOGY INTERNATIONAL (2010)
Cytokine and Cytokine-Like Inflammation Markers, Endothelial Dysfunction, and Imbalanced Coagulation in Development of Diabetes and Its Complications
Ronald B. Goldberg
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets
Annette H. M. van der Helm-van Mil et al.
ARTHRITIS RESEARCH & THERAPY (2008)
DPP-4 inhibitors
Bo Ahren
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes - Preclinical biology and mechanisms of action
Daniel J. Drucker
DIABETES CARE (2007)
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial
M. A. Nauck et al.
DIABETES OBESITY & METABOLISM (2007)
Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes
Pablo Aschner et al.
DIABETES CARE (2006)
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus
I. Raz et al.
DIABETOLOGIA (2006)
The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis
AHM van der Helm-van Mil et al.
ARTHRITIS AND RHEUMATISM (2006)
Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis - Contrasting effects of HLA-DR3 and the shared epitope alleles
P Irigoyen et al.
ARTHRITIS AND RHEUMATISM (2005)
Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins
TWJ Huizinga et al.
ARTHRITIS AND RHEUMATISM (2005)
Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis
KN Verpoort et al.
ARTHRITIS AND RHEUMATISM (2005)
Circulating CD26 is negatively associated with inflammation in human and experimental arthritis
N Busso et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Dipeptidyl peptidase IV activity and/or structure homologs: Contributing factors in the pathogenesis of rheumatoid arthritis?
A Sedo et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Incretins, insulin secretion and Type 2 diabetes mellitus
T Vilsboll et al.
DIABETOLOGIA (2004)
Circulation and degradation of GIP and GLP-1
CF Deacon
HORMONE AND METABOLIC RESEARCH (2004)
Deficiency of CD26 results in a change of cytokine and immunoglobulin secretion after stimulation by pokeweed mitogen
SL Yan et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Homing chemokines in rheumatoid arthritis
P Loetscher et al.
ARTHRITIS RESEARCH (2002)
Serum interleukin-12, interieukin-15, soluble CD26, and adenosine deaminase in patients with rheumatoid arthritis
OJ Cordero et al.
RHEUMATOLOGY INTERNATIONAL (2001)
Mig, GROα and RANTES messenger RNA expression in lining layer, infiltrates and different leucocyte populations of synovial tissue from patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritis
A König et al.
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY (2000)
Share Paper
